Fate Therapeutics Inc Cash Flow-to-Debt Ratio
Fate Therapeutics Inc cash flow-to-debt ratio. Fate Therapeutics Inc (FATE) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of $-24.37 Million could theoretically repay 0% of its total liabilities ($109.61 Million) in one year. See financial agility of Fate Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Fate Therapeutics Inc (2011–2024)
Cash flow-to-debt ratio of Fate Therapeutics Inc from 2011 to 2024. Historical debt coverage capacity for Fate Therapeutics Inc across 14 annual periods. Check cash flow reinvestment rate of Fate Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Fate Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2011–2024)
Fate Therapeutics Inc cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Fate Therapeutics Inc. For the full cash flow conversion analysis, see Fate Therapeutics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.01x | $-122.87 Million | $121.97 Million | ▼ -5.0% |
| 2023 | -0.96x | $-132.26 Million | $137.80 Million | ▲ +14.3% |
| 2022 | -1.12x | $-248.21 Million | $221.62 Million | ▼ -66.8% |
| 2021 | -0.67x | $-162.87 Million | $242.62 Million | ▼ -307.3% |
| 2020 | -0.16x | $-39.23 Million | $238.01 Million | ▲ +88.6% |
| 2019 | -1.45x | $-83.17 Million | $57.52 Million | ▼ -96.7% |
| 2018 | -0.74x | $-38.65 Million | $52.56 Million | ▲ +44.0% |
| 2017 | -1.31x | $-36.91 Million | $28.10 Million | ▲ +3.6% |
| 2016 | -1.36x | $-29.82 Million | $21.89 Million | ▼ -121.5% |
| 2015 | -0.61x | $-18.40 Million | $29.92 Million | ▲ +37.3% |
| 2014 | -0.98x | $-22.42 Million | $22.86 Million | ▲ +69.8% |
| 2013 | -3.25x | $-15.37 Million | $4.74 Million | ▼ -1462.9% |
| 2012 | -0.21x | $-13.27 Million | $63.90 Million | ▼ -0.1% |
| 2011 | -0.21x | $-12.14 Million | $58.53 Million | — |